Dueling for dual inhibition: Means to enhance effectiveness of PI3K/Akt/mTOR inhibitors in AML
Author:
Publisher
Elsevier BV
Subject
Oncology,Hematology
Reference163 articles.
1. Adult acute myeloid leukaemia;Smith;Crit Rev Onc Hem,2004
2. Progress in the treatment of acute myeloid leukemia;Ravandi;Cancer,2007
3. Midostaurin plus chemotherapy for acute myeloid leukemia with a FLT3 mutation;Stone;N Engl J Med,2017
4. Enasidenib in mutant IDH2 relapsed or refractory acute myeloid leukemia;Stein;Blood,2017
5. Gumtuzumab ozogamicin in acute myeloid leukemia;Godwin;Leukemia,2017
Cited by 51 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Potential of β-D-glucan polysaccharide from Ophiocordyceps sinensis OS8 cultivated mycelium on anticancer activity via inducing liver cancer cell death apoptosis;Process Biochemistry;2024-10
2. JR-AB2-011 induces fast metabolic changes independent of mTOR complex 2 inhibition in human leukemia cells;Pharmacological Reports;2024-09-11
3. Recent Advances in Signaling Pathways and Kinase Inhibitors for Leukemia Chemotherapy;Current Medicinal Chemistry;2024-02-16
4. Rational design and optimization of novel 4-methyl quinazoline derivatives as PI3K/HDAC dual inhibitors with benzamide as zinc binding moiety for the treatment of acute myeloid leukemia;European Journal of Medicinal Chemistry;2024-01
5. Design, synthesis and antitumor effects of novel benzimidazole derivatives as PI3K inhibitors;Bioorganic & Medicinal Chemistry Letters;2023-10
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3